PCSK9 inhibition for patients with and without prior coronary revascularization: Potential additional benefit of a novel therapeutic agent

被引：2
|
作者：
Navarese, Eliano P. [1 ,2 ,3 ,4 ]
Raggi, Paolo [4 ,5 ]
机构：
[1] INOVA Heart & Vasc Inst, Fairfax, VA USA
[2] Mater Dei Hosp, Cardiovasc Res Ctr, Intervent Cardiol & Cardiovasc Res, Bari, Italy
[3] SIRIO Med Network, Milan, Italy
[4] Mazankowski Alberta Heart Inst, 8440 112 St,5A9-014, Edmonton, AB T6G 2B7, Canada
[5] Univ Alberta, Dept Med, Edmonton, AB, Canada
来源：
ATHEROSCLEROSIS | 2018年 / 277卷
关键词：
PCSK9; Lipid lowering; Lipoproteins; Low density lipoprotein cholesterol; LIPOPROTEIN(A);
D O I：
10.1016/j.atherosclerosis.2018.07.038
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：177 / 178
页数：2
相关论文
共 29 条
  • [21] Unraveling the rapid progression of non-target lesions: risk factors and the therapeutic potential of PCSK9 inhibitors in post-PCI patients
    Mei, Jiajie
    Fu, Xiaodan
    Liu, Zhenzhu
    Zhang, Lijiao
    Geng, Zhaohong
    Xie, Wenli
    Yu, Ming
    Wang, Yuxing
    Zhao, Jinglin
    Zhang, Xiaodong
    Yin, Lili
    Qu, Peng
    BMC CARDIOVASCULAR DISORDERS, 2024, 24 (01):
  • [22] THE FAST-MI 2005-2010-2015 REGISTRIES IN LIGHT OF THE ODYSSEY TRIAL: POTENTIAL INDICATIONS FOR PCSK9 INHIBITION IN ACS PATIENTS
    Schiele, Francois
    Puymirat, Etienne
    Ferrieres, Jean
    Simon, Tabassome
    Danchin, Nicolas
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 197 - 197
  • [23] Is the novel LDL-cholesterol goal <1.4 mmol/L achievable without a PCSK9 inhibitor in a chronic coronary population from clinical practice?
    Munkhaugen, John
    Sverre, Elise
    Peersen, Kari
    Kristiansen, Oscar
    Gjertsen, Erik
    Gullestad, Lars
    Erik Otterstad, Jan
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2021, 28 (08) : E10 - E11
  • [24] Association of circulating PCSK9 concentration with cardiovascular metabolic markers and outcomes in stable coronary artery disease patients with or without diabetes: a prospective, observational cohort study
    Peng, Jia
    Liu, Ming-Ming
    Jin, Jing-Lu
    Cao, Ye-Xuan
    Guo, Yuan-Lin
    Wu, Na-Qiong
    Zhu, Cheng-Gang
    Dong, Qian
    Sun, Jing
    Xu, Rui-Xia
    Li, Jian-Jun
    CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)
  • [25] Association of circulating PCSK9 concentration with cardiovascular metabolic markers and outcomes in stable coronary artery disease patients with or without diabetes: a prospective, observational cohort study
    Jia Peng
    Ming-Ming Liu
    Jing-Lu Jin
    Ye-Xuan Cao
    Yuan-Lin Guo
    Na-Qiong Wu
    Cheng-Gang Zhu
    Qian Dong
    Jing Sun
    Rui-Xia Xu
    Jian-Jun Li
    Cardiovascular Diabetology, 19
  • [26] Novel circulating lipid measurements for current dyslipidemias in non-treated patients undergoing coronary angiography: PCSK9, apoC3 and sdLDL-C
    Li, Sha
    Zhao, Xi
    Zhang, Yan
    Zhu, Cheng-Gang
    Guo, Yuan-Lin
    Wu, Na-Qiong
    Xu, Rui-Xia
    Qing, Ping
    Gao, Ying
    Sun, Jing
    Liu, Geng
    Dong, Qian
    Li, Jian-Jun
    ONCOTARGET, 2017, 8 (07) : 12333 - 12341
  • [27] A Novel Therapeutic Approach to Intensive Statin Therapy-Resistant Vulnerable Plaque of Coronary Artery in Diabetic Patients by Use of Anti-PCSK9 Antibody and Coronary CT Angiography (CCTA)
    Hirai, Aizan
    Fujimura, Koji
    Kondo, Seiya
    Sakai, Takenori
    Ikejima, Shin
    Taniai, Hisanori
    Hirai, Keiji
    Murata, Kazuya
    Shirakami, Atsushi
    Okuzaki, Kazutoshi
    Kageyama, Takahiro
    DIABETES, 2018, 67
  • [28] Mortality Risk and Therapeutic Benefit of Coronary Revascularization versus Medical Therapy in 15,223 Patients Without Known Coronary Artery Disease Undergoing Coronary CT Angiography: Results from the CONFIRM Registry (COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter Registry)
    Min, James K.
    Achenbach, Stephan
    Al-Mallah, Mouaz
    Budoff, Matthew J.
    Cademartiri, Filippo
    Callister, Tracy Q.
    Chang, Hyuk J.
    Cheng, Victor Y.
    Chow, Benjamin J.
    Delago, Augustin J.
    Dunning, Allison M.
    Hadamitzky, Martin
    Leipsic, Jonathon
    Hausleiter, Joerg
    Kaufmann, Philipp A.
    Lin, Fay Y.
    Maffei, Erica
    Raff, Gilbert L.
    Villines, Todd C.
    Shaw, Leslee J.
    Berman, Daniel S.
    CIRCULATION, 2011, 124 (21)
  • [29] Consensus on using cardiac computed tomography for planning coronary revascularisation; efficacy of early PCSK9 inhibitor treatment in primary PCI; ticagrelor monotherapy in PCI patients with prior CABG; complex PCI and the impact of different stent polymers; CTO-PCI and coronary collateral function; best care for MINOCA patients; and more
    Capodanno, Davide
    EUROINTERVENTION, 2022, 18 (11) : 1 - 3
123